Trial Profile
Clinical Trials Insight: 700049387
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 30 Sep 2009
Price :
$35
*
At a glance
- Drugs Lapuleucel T (Primary)
- Indications Bladder cancer
- Focus Adverse reactions
- Sponsors Dendreon Corporation
- 30 Sep 2009 New trial record.